AAM
BSX icon

Archipel Asset Management’s Boston Scientific BSX Stock Holding History

Archipel Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7.63M Buy
645,702
+16,110
+3% +$203K 2.2% 5
2014
Q2 		$8.04M Hold
629,592
– – 2.01% 31
2014
Q1 		$8.51M Buy
+629,592
New +$8.26M 2.2% 16

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Archipel Asset Management's BSX Position: Q3 2014 in Review

Archipel Asset Management increased its Boston Scientific (BSX) stake by 2.6% in Q3 2014, buying an estimated $203K and bringing the position to 645,702 shares worth $7.63M. The position accounts for 2.2% of the portfolio, ranked #5.

Archipel Asset Management first reported a position in BSX in Q1 2014 and has held it in 3 quarters since. The position peaked at $8.51M in Q1 2014. 435 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

  • Archipel Asset Management held 645,702 shares of Boston Scientific worth $7.63M as of Q3 2014.
  • Archipel Asset Management bought 16,110 Boston Scientific shares in Q3 2014, an estimated $203K.
  • Boston Scientific made up 2.2% of Archipel Asset Management's portfolio in Q3 2014, its #5 holding.
  • Archipel Asset Management first reported a position in Boston Scientific in Q1 2014 and has held it in 3 quarters since.
  • Archipel Asset Management's Boston Scientific position peaked at $8.51M in Q1 2014.
  • 435 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Archipel Asset Management's 13F filing for Q3 2014, filed 15 Oct 2014.